As of 2025-05-17, the EV/EBITDA ratio of NantHealth Inc (NH) is -8.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NH's latest enterprise value is 336.09 mil USD. NH's TTM EBITDA according to its financial statements is -37.78 mil USD. Dividing these 2 quantities gives us the above NH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 13.0x | 11.1x |
| Forward P/E multiples | 9.5x - 21.1x | 15.2x |
| Fair Price | (88.87) - (106.03) | (106.77) |
| Upside | -6682.7% - -7954.1% | -8008.6% |
| Date | EV/EBITDA |